Rodríguez-Mañero M., Baluja A., Hernández J., Muñoz C., Calvo D., Fernández-Armenta J., García-Fernández A., Zorio E., Arce-León Á., Sánchez-Gómez J.M., Mosquera-Pérez I., Arias M.Á., Díaz-Infante E., Expósito V., Jiménez-Ramos V., Teijeira E., Cañadas-Godoy M.V., Guerra-Ramos J.M., Oloriz T., Basterra N., Sousa P., Elices-Teja J., García-Bolao I., González-Juanatey J.R., Brugada R., Gimeno J.R., Brugada J., Arbelo E.. Validation of multiparametric approaches for the prediction of sudden cardiac death in patients with Brugada syndrome and electrophysiological study. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(7)DOI:10.1016/j.recesp.2021.07.006. PMID:. IF:(Q/D).

Farkowski, MM, Guerra, JM, Marijon, E, Boveda, S. Long-term quality of life and acceptance of implantable cardioverter-defibrillator therapy: results of the European Heart Rhythm Association survey (Apr, 10.1093/europace/euac011, 2022). EUROPACE. 2022; 24(7)DOI:10.1093/europace/euac051. PMID:. IF:6.100(Q1/3D).

Gorog, DA, Storey, RF, Gurbel, PA, Tantry, US, Berger, JS, Chan, MY, Duerschmied, D, Smyth, SS, Parker, WAE, Ajjan, RA, Vilahur, G, Badimon, L, ten Berg, JM, ten Cate, H, Peyvandi, F, Wang, TT, Becker, RC. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nature Reviews Cardiology. 2022; 19(7)DOI:10.1038/s41569-021-00665-7. PMID:35027697. IF:49.600(Q1/1D).

Gharanei M., Shafaattalab S., Sangha S., Gunawan M., Laksman Z., Hove-Madsen L., Tibbits G.F.. Atrial-specific hiPSC-derived cardiomyocytes in drug discovery and disease modeling. METHODS. 2022; 203DOI:10.1016/j.ymeth.2021.06.009. PMID:34144175. IF:4.800(Q1/2D).